These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8873013)

  • 1. Surgical perspective on prostate cancer. Detection, staging, and treatment.
    Loughlin KR
    Magn Reson Imaging Clin N Am; 1996 Aug; 4(3):449-69. PubMed ID: 8873013
    [No Abstract]   [Full Text] [Related]  

  • 2. The current management of carcinoma of the prostate.
    Rodriguez R; Carter HB
    Adv Surg; 1999; 33():181-97. PubMed ID: 10572567
    [No Abstract]   [Full Text] [Related]  

  • 3. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of surgical margins in prostate cancer.
    Sooriakumaran P; Dev HS; Skarecky D; Ahlering T
    J Surg Oncol; 2016 Mar; 113(3):310-5. PubMed ID: 27004601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Lynch MJ
    J Urol; 2005 Sep; 174(3):1155; author reply 1155-6. PubMed ID: 16094096
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostate cancer screening with a new marker based on circulating blood macrophages?].
    Herwig R; Djavan B; Kramer G; El-Taieb MA; Kühhas F; Leers M; Marberger M
    Urologe A; 2007 Sep; 46(9):1066-70. PubMed ID: 17622505
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer: European urologists prefer surgery for high-risk prostate cancer.
    Payton S
    Nat Rev Urol; 2014 Jun; 11(6):307. PubMed ID: 24861331
    [No Abstract]   [Full Text] [Related]  

  • 8. [Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression?].
    Wirth M
    Urologe A; 1998 Jul; 37(4):427-8. PubMed ID: 9738298
    [No Abstract]   [Full Text] [Related]  

  • 9. Surgical management of prostate cancer: advances based on a rational approach to the data.
    Meraney AM; Haese A; Palisaar J; Graefen M; Steuber T; Huland H; Klein EA
    Eur J Cancer; 2005 Apr; 41(6):888-907. PubMed ID: 15808956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: detection, staging, and treatment of localized disease.
    Potter SR; Partin AW
    Semin Roentgenol; 1999 Oct; 34(4):269-83. PubMed ID: 10553603
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer imaging.
    Kundra V
    Semin Roentgenol; 2006 Apr; 41(2):139-49. PubMed ID: 16697892
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
    Taneja SS
    J Urol; 2015 Dec; 194(6):1631-2. PubMed ID: 26582665
    [No Abstract]   [Full Text] [Related]  

  • 13. [Status of PSA determination for early detection of prostate carcinoma].
    Hammerer P; Huland H
    Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging prostate cancer--1997: current methods and limitations.
    Bostwick DG
    Eur Urol; 1997; 32 Suppl 3():2-14. PubMed ID: 9267781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant therapy of locally advanced prostate carcinoma with ibandronate].
    Lindenmeir T; Ulrich M; Rau O; Reiher F; Allhoff EP
    Urologe A; 2007 Sep; 46(9):1287. PubMed ID: 17694295
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening for the early diagnosis of prostatic carcinoma in Ossola: results after 1 year of effort].
    Pagani G; Iannicelli P; Rosa A; Aimè G; Ceratti G; Cobianchi PG
    Arch Ital Urol Androl; 1994 Feb; 66(1):47-50. PubMed ID: 7516781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
    Stenman UH
    Eur Urol; 2007 Oct; 52(4):1074-5. PubMed ID: 17383813
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radical perineal prostatectomy].
    Fichtner J; Stackl W; Thüroff JW
    Aktuelle Urol; 2008 Sep; 39(5):381-94. PubMed ID: 18798129
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Rosser CJ; Parker A
    J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.